80% of Gen Z think cannabis should be legal in the UK

80%-of-gen-z-think-cannabis-should-be-legal-in-the-uk

A report published this week by The National Centre for Social Research (NatCen) has found that 80% of Generation Z support the legalisation of cannabis in the United Kingdom. The report, titled Society Watch 2024: Understanding the new generation of voters, provides insight into three key policy issues ahead of the upcoming General Election; law and order

WEEDGANGSTA Power Share:

One in four UK police officers unaware that medical cannabis is legal

A cross-sectional survey of serving police officers has found that over one in four respondents were unaware that cannabis can be prescribed legally in the UK. The survey, conducted between 24 October and 1 November 2022, was designed by a multi-disciplinary team of academic clinicians and a cognitive neuroscientist. It was then distributed to serving

WEEDGANGSTA Power Share:

Cookies branded cannabis coming to UK medical market

The high-profile Californian cannabis brand Cookies will soon be available in the UK and Europe, after the company signed a deal to distribute dried flower and extracts with Portugal-based biotech company SOMAÍ. The deal, which will allow SOMAÍ to exclusively cultivate, manufacture, and distribute on behalf of Cookies, will see a range of branded products

WEEDGANGSTA Power Share:

Cannabis compound could be used as treatment for Alzheimer’s and Parkinson’s disease

Researchers at the Salk Institute, a non-profit research organisation, have found that the cannabinoid CBN (cannabinol) may be able to treat neurological disorders such as Alzheimer’s and Parkinson’s disease. In the study, published in the journal Redox Biology, researchers first used existing data from previous studies to understand how naturally occurring CBN has helped to

WEEDGANGSTA Power Share:

Patients living with MS report better quality of life after being prescribed cannabis

patients-living-with-ms-report-better-quality-of-life-after-being-prescribed-cannabis

Researchers from the Imperial College Medical Cannabis Research Group have published a study showing that patients with Multiple Sclerosis (MS) report significant improvements in health-related quality of life after 6 months of treatment with cannabis. Current treatment for MS focuses on slowing down the progression of the neurodegenerative disease, these therapies are known as disease-modifying

WEEDGANGSTA Power Share:

DMT shows positive results in trials for the treatment and prevention of Alzheimer’s disease

dmt-shows-positive-results-in-trials-for-the-treatment-and-prevention-of-alzheimer’s-disease

A study published in the journal BioMed Central has shown how the psychedelic N, N-Dimethyltryptamine (DMT) could be used as a medicine to prevent the onset of the neurodegenerative condition Alzheimer’s disease (AD).  According to the NHS, Alzheimer’s disease is the most common cause of dementia in the UK. Symptoms of Azheimer’s range from minor

WEEDGANGSTA Power Share:

Rolling papers may be contaminated with unsafe levels of heavy metals

rolling-papers-may-be-contaminated-with-unsafe-levels-of-heavy-metals

Researchers concerned with the lack of regulation in the rolling paper industry have published a study in which they analysed 53 rolling paper products available on the US consumer market. The objective of the study, published in the journal ACS Omega was to evaluate if these products were potentially causing a risk to the health

WEEDGANGSTA Power Share:

DEA set to reschedule cannabis in the US as bill introduced that could lead to full legalisation

dea-set-to-reschedule-cannabis-in-the-us-as-bill-introduced-that-could-lead-to-full-legalisation

Eight months after the Biden administration ordered a review into cannabis law, the DEA, the agency that enforces drug law in the United States announced that it would reschedule cannabis from Schedule I to Schedule III. The announcement means that cannabis will no longer be Schedule I, a category that contains drugs such as heroin

WEEDGANGSTA Power Share:

Cannabis consumers are not ‘lazy stoners’ study finds

A study published in the journal Social Psychological and Personality Science has found that chronic cannabis users are motivated and exhibit willingness to carry out tasks that require effort, contrary to the stereotype that stoners are lazy. The study queried 260 cannabis consumers five times per day over a period of seven days. Using a

WEEDGANGSTA Power Share: